BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 11398196)

  • 1. Transformation of kidney epithelial cells by a quinol thioether via inactivation of the tuberous sclerosis-2 tumor suppressor gene.
    Yoon HS; Monks TJ; Walker CL; Lau SS
    Mol Carcinog; 2001 May; 31(1):37-45. PubMed ID: 11398196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carcinogenicity of a nephrotoxic metabolite of the "nongenotoxic" carcinogen hydroquinone.
    Lau SS; Monks TJ; Everitt JI; Kleymenova E; Walker CL
    Chem Res Toxicol; 2001 Jan; 14(1):25-33. PubMed ID: 11170505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in gene expression during chemical-induced nephrocarcinogenicity in the Eker rat.
    Patel SK; Ma N; Monks TJ; Lau SS
    Mol Carcinog; 2003 Nov; 38(3):141-54. PubMed ID: 14587099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ERK crosstalks with 4EBP1 to activate cyclin D1 translation during quinol-thioether-induced tuberous sclerosis renal cell carcinoma.
    Cohen JD; Gard JM; Nagle RB; Dietrich JD; Monks TJ; Lau SS
    Toxicol Sci; 2011 Nov; 124(1):75-87. PubMed ID: 21813464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced constitutive 8-oxoguanine-DNA glycosylase expression and impaired induction following oxidative DNA damage in the tuberin deficient Eker rat.
    Habib SL; Phan MN; Patel SK; Li D; Monks TJ; Lau SS
    Carcinogenesis; 2003 Mar; 24(3):573-82. PubMed ID: 12663520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. cAMP-dependent cytosolic mislocalization of p27(kip)-cyclin D1 during quinol-thioether-induced tuberous sclerosis renal cell carcinoma.
    Cohen JD; Tham KY; Mastrandrea NJ; Gallegos AC; Monks TJ; Lau SS
    Toxicol Sci; 2011 Aug; 122(2):361-71. PubMed ID: 21693435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell proliferation is insufficient, but loss of tuberin is necessary, for chemically induced nephrocarcinogenicity.
    Yoon HS; Monks TJ; Everitt JI; Walker CL; Lau SS
    Am J Physiol Renal Physiol; 2002 Aug; 283(2):F262-70. PubMed ID: 12110509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tuberous sclerosis-2 tumor suppressor modulates ERK and B-Raf activity in transformed renal epithelial cells.
    Yoon HS; Ramachandiran S; Chacko MA; Monks TJ; Lau SS
    Am J Physiol Renal Physiol; 2004 Feb; 286(2):F417-24. PubMed ID: 14612383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of ERK1/2 and histone H3 phosphorylation within the outer stripe of the outer medulla of the Eker rat by 2,3,5-tris-(glutathion-S-yl)hydroquinone.
    Dong J; Everitt JI; Lau SS; Monks TJ
    Toxicol Sci; 2004 Aug; 80(2):350-7. PubMed ID: 15129024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Up-regulation of hypoxia-inducible factor 2alpha in renal cell carcinoma associated with loss of Tsc-2 tumor suppressor gene.
    Liu MY; Poellinger L; Walker CL
    Cancer Res; 2003 May; 63(10):2675-80. PubMed ID: 12750296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stress- and growth-related gene expression are independent of chemical-induced prostaglandin E(2) synthesis in renal epithelial cells.
    Towndrow KM; Mertens JJ; Jeong JK; Weber TJ; Monks TJ; Lau SS
    Chem Res Toxicol; 2000 Feb; 13(2):111-7. PubMed ID: 10688535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of loss of heterozygosity in frozen and paraffin embedded tumors by denaturating high-performance liquid chromatography (DHPLC).
    Kleymenova E; Walker CL
    J Biochem Biophys Methods; 2001 Jan; 47(1-2):83-90. PubMed ID: 11179764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal cortical cells and astrocytomas in the Eker rat model of tuberous sclerosis complex.
    Takahashi DK; Dinday MT; Barbaro NM; Baraban SC
    Epilepsia; 2004 Dec; 45(12):1525-30. PubMed ID: 15571510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutagenicity and carcinogenicity of biological reactive intermediate's derived from a "non-genotoxic" carcinogen.
    Lau SS; Yoon HS; Patel SK; Everitt JI; Walker CL; Monks TJ
    Adv Exp Med Biol; 2001; 500():83-92. PubMed ID: 11765020
    [No Abstract]   [Full Text] [Related]  

  • 15. Increased susceptibility to in vitro transformation of cells carrying the Eker tumor susceptibility mutation.
    Horesovsky G; Ginsler J; Everitt J; Walker C
    Carcinogenesis; 1994 Oct; 15(10):2183-7. PubMed ID: 7955051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential regulation of redox responsive transcription factors by the nephrocarcinogen 2,3,5-Tris(glutathion-S-yl)hydroquinone.
    Weber TJ; Huang Q; Monks TJ; Lau SS
    Chem Res Toxicol; 2001 Jul; 14(7):814-21. PubMed ID: 11453727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tuberin haploinsufficiency is associated with the loss of OGG1 in rat kidney tumors.
    Habib SL; Simone S; Barnes JJ; Abboud HE
    Mol Cancer; 2008 Jan; 7():10. PubMed ID: 18218111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunochemical analysis of quinol-thioether-derived covalent protein adducts in rodent species sensitive and resistant to quinol-thioether-mediated nephrotoxicity.
    Kleiner HE; Jones TW; Monks TJ; Lau SS
    Chem Res Toxicol; 1998 Nov; 11(11):1291-300. PubMed ID: 9815189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal cell carcinoma development in the rat independent of alterations at the VHL gene locus.
    Walker C; Ahn YT; Everitt J; Yuan X
    Mol Carcinog; 1996 Feb; 15(2):154-61. PubMed ID: 8599582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The genetic basis of kidney cancer: why is tuberous sclerosis complex often overlooked?
    Henske EP
    Curr Mol Med; 2004 Dec; 4(8):825-31. PubMed ID: 15579029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.